© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
560220 |
As an accredited 2-Bromo-5-(Trifluoromethoxy)Aniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-5-(Trifluoromethoxy)Aniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every so often, a new chemical grabs the attention of both researchers and production managers because of its versatility and the fresh approach it brings to industrial processes. 2-Bromo-5-(Trifluoromethoxy)Aniline stands out among building blocks in organic synthesis. With the formula C7H5BrF3NO, this compound draws interest from pharmaceutical labs and specialty chemical development teams. You don’t hear about it outside of chemical circles all that often, but its fingerprints show up on a surprisingly wide array of advanced molecules.
Chemically, 2-Bromo-5-(Trifluoromethoxy)Aniline features a bromine atom and a trifluoromethoxy group attached to the aromatic ring of an aniline molecule. The IUPAC name spells out its structure: 2-bromo-5-(trifluoromethoxy)aniline. The presence of both the electron-withdrawing bromine and the highly electronegative trifluoromethoxy group changes the properties of the base aniline significantly.
On the technical side, pure samples of this product present as a pale-yellow to light brown crystalline solid. Its molecular weight sits around 256.02 g/mol. Its melting point ranges between 56 °C and 59 °C, which is handy for labs with straightforward purification requirements. The CAS number identifies it as 1072958-22-9, which makes finding references straightforward for professionals hunting through journals or ordering catalogs.
Handling often requires the same protocols you’d use for other fluorinated aromatic amines. The trifluoromethoxy group increases resistance to metabolic degradation and UV breakdown, which helps the compound stick around during harsh reaction conditions or energetic steps involved in scale-up processing.
Often, chemists use 2-Bromo-5-(Trifluoromethoxy)Aniline as a building block for synthesizing more complex molecules. Its popularity comes partly from the way it delivers both reactivity and stability. This dual feature is not so easy to find. Researchers value the site-selective reactivity the bromo group affords—making it a go-to compound for coupling reactions, especially in the Buchwald-Hartwig amination or Suzuki-Miyaura cross-coupling. The bromo position enables easy installation of aryl or alkyl fragments, giving scientists control in designing tailored molecules and expanding compound libraries quickly.
The trifluoromethoxy group plays its role by offering lipophilicity and metabolic stability—traits that medicinal chemists covet when modifying lead structures to optimize their profile for clinical testing. The trifluoromethoxy moiety’s influence on electronic properties and hydrogen-bonding capacity shapes how new molecules interact with biological targets. This quality makes 2-Bromo-5-(Trifluoromethoxy)Aniline a favorite intermediate for synthesizing kinase inhibitors, antiviral agents, and agrochemicals. A fair share of patents mention this molecule in their synthetic claims as a precursor for molecules aimed at everything from crops to oncology.
Structural modifications define much of modern drug and agrochemical design. Fluorination has gained ground over the past two decades because the addition of CF3O or similar groups extends metabolic lifetime and introduces new binding opportunities with protein targets. Few aniline derivatives provide as strong a combination as you get here. A regular bromoaniline offers plenty as a basic platform, but it misses the improved bioavailability and binding affinity delivered by trifluoromethoxy groups. On the flip side, most fluorinated aniline compounds do not include reactive halides, which limits their flexibility for downstream reactions.
2-Bromo-5-(Trifluoromethoxy)Aniline brings together both features. The bromo function attaches to the ring ortho to the amino group, which enables regioselective functionalization in ways that unsubstituted analogs simply can’t match. Incorporating the trifluoromethoxy group not only changes the electronic density of the ring but also alters solubility and increases the hydrophobic profile. This blend supports easy tuning of new molecules for a range of targets—pharmaceutical or otherwise.
Plenty of chemists have worked with the classic aniline, para-bromoaniline, or trifluoroaniline derivatives over the years. In practice, there’s a ceiling to what can be achieved by swapping out just one functional group. Adding bromine to the aniline structure certainly opens doors to cross-coupling, but it doesn’t do much for clearance rates in living systems or for extending shelf life under tough production conditions. By splitting the difference and taking on both a reactive halide and a stable, electron-withdrawing group, this compound grants chemists extra freedom.
For example, if you take standard 2-bromoaniline, you get good reactivity but poor metabolic properties for most drug development tasks. On the other hand, a molecule like 5-(trifluoromethoxy)aniline, which skips the halide, works fine in early library development but often bottlenecks at late-stage diversification. With both modifications present, scientists can take a single molecule through catalytic cross-coupling, then fine-tune the amine or aryl positions to get better results in terms of solubility, biological properties, or even environmental stability.
What stands out from experience is that each extra degree of freedom in molecular design pays exponential dividends in exploratory chemistry. Teams racing to file new patent claims, tweak selectivity, or work out better metabolic profiles need intermediates that don’t box them in. This aniline derivative demonstrates what happens when you combine classic coupling flexibility with the benefits of strategic fluorination. You notice a marked reduction in compound attrition rates: fewer dead ends, more options for molecular diversification, and a better shot at landing on a “hit” compound.
Looking back at the last decade in medicinal and agrochemical research, the push for “druggable” properties has changed what people ask from their building blocks. Basic structural scaffolds with low metabolic stability or poor selectivity are moving out of favor, replaced by compounds already tuned for metabolic and electronic characteristics. The inclusion of a trifluoromethoxy group skirts around the pitfalls of rapid degradation or low bioavailability, reducing time lost in iterative optimization. Every day shaved off pre-clinical development means money saved and a lower barrier to innovation.
This aniline’s design aligns with the needs of groups seeking a shortcut—some way to shave off dead weight in candidate selection. With some intermediates, you run a synthesis, test the product, and end up discarding entire lines of inquiry due to solubility or metabolic issues. If you can narrow your options from the start using a smarter scaffold, you waste less. There’s something rewarding about knowing you’re not just making up for a lack of reactivity or stability at the tail end, but planning for it from the first step.
Trust in specialty chemicals comes from a mix of repeatable chemistry and reliable sourcing. The best labs in the world often hit a wall not because a reaction is impossible, but because the quality of intermediates fluctuates from batch to batch. 2-Bromo-5-(Trifluoromethoxy)Aniline, once sourced through verified channels, brings a degree of consistency that’s tough to find in many niche aniline derivatives. Each batch needs to be tested for purity—usually by HPLC, NMR, or GC—to ensure no isomeric impurity levels compromise downstream reactions. A small deviation early can turn an entire synthetic run into a write-off.
Having worked in both academic and industrial labs, experience teaches that inconsistency in intermediate purity can lead to misleading reaction data, especially where catalysis is sensitive to trace contaminants. With a structure as specific as this one, analytical transparency matters as much as synthetic ease. Measurements of melting point, identification by spectroscopic signature, and confirmation of the bromo/trifluoromethoxy placement all contribute to robustness—not just on paper, but in daily lab practice.
Different vendors set their own benchmarks for batch testing. More advanced suppliers include detailed impurity profiles, supported by up-to-date analytical techniques. This level of care pushes up the baseline for reproducibility in high-value synthetic campaigns. The labs that commit to regular quality validation are better equipped to bring their discoveries across the gap from research to pilot scale.
Most aromatic amines come with some handling warnings, and 2-Bromo-5-(Trifluoromethoxy)Aniline is no exception. Direct skin contact or inhalation should always be avoided—regular gloves, lab coats, and fume hoods go a long way. While anilines are familiar territory, the addition of bromine and trifluoromethoxy does affect solubility and volatility. Ensuring the compound stays dry and optimizing your protocols for each use keeps it safe and efficient. Correct disposal matters, too; traces of halogenated and fluorinated compounds in waste streams need to be minimized.
A bit of care in container sealing prevents contamination with atmospheric moisture or unintended oxidation. Even though trifluoromethoxy delivers some resistance to breakdown, its presence can lead to stubborn reactivity if exposed to inappropriate conditions. For scale-up, using inert gas blankets and monitoring for heat spikes keeps both product and personnel protected. The learning curve here isn’t steep, but it rewards prudent, well-practiced safety habits—especially for those less familiar with fine chemicals that blend halide and fluorinated functionalities.
Fluorine chemistry, once a fringe topic, now shapes how researchers select intermediates for the next generation of drugs and crop protectants. As more biotech teams focus on resistant pathogens and changing global climates, the need for stable yet highly modifiable molecules climbs. Fluorinated anilines in particular have stepped into this gap because they deliver reliability without locking chemists into one narrow channel of synthesis.
With experience, you notice a few patterns: though adding a trifluoromethoxy group or a bromo atom separately can improve selectivity or enable essential coupling, rare is the case where combining both pays off so cleanly for both research and process optimization. New cross-coupling methods now favor structures that include both groups, cutting out extra protecting/deprotecting steps. This boosts throughput and helps research budgets go further. Small changes in the way basic scaffolds are designed drive downstream advancements in whole sectors of pharmaceutical discovery.
In a world where regulatory frameworks are getting tougher and costs keep rising, access to intermediates that minimize waste and downtime is a survival strategy. 2-Bromo-5-(Trifluoromethoxy)Aniline streamlines the route from conception to candidate molecule, giving medichem teams a real shot at “fail fast, iterate faster” workflows. More seasoned chemists comment on how rare it is to find a structure that isn’t pigeonholed by either reactivity or stability—but this molecule marks a real exception.
One big challenge facing those using specialty intermediates involves balancing purity, scale, and price. Regular commodity chemicals benefit from large supply chains, but a derivative like 2-Bromo-5-(Trifluoromethoxy)Aniline needs more careful planning. For small labs and large-scale operations alike, a few strategies help keep projects on track without risking output quality:
One overlooked solution is more deliberate collaboration between industry and academia. Rather than developing sourcing or purification workflows in isolation, open dialogue about challenges pushes innovation in purification and waste management strategies. The best breakthroughs often happen not in solitary effort, but in small workshops where chemists swap stories from the bench. Real-world experience trumps theoretical best practices, as long as it’s documented and shared transparently.
As research turns toward tougher therapeutic targets or more challenging agricultural problems, the need for intermediates like 2-Bromo-5-(Trifluoromethoxy)Aniline will likely rise. Its current use sits mostly in discovery-stage programs and specialty process chemistry. Even outside pharma or crop protection, the peculiar blend of stability and reactivity makes it appealing for organic electronics, advanced materials, or chemical sensors. Some development teams explore new dye molecules by swapping in trifluoromethoxy-containing scaffolds, chasing better stability for long-term outdoor use or photostability improvements—areas where standard anilines fall short.
It comes down to flexibility: the ability to move from a basic, well-characterized starting point toward a vast array of target molecules. Innovation in any chemical sector, from catalysts to diagnostic reagents, relies on intermediates that don’t dead-end in one niche application. A decade ago, few would have bet on the mainstreaming of fluorinated aromatic amines. Now, familiarity with their handling, broader incorporation in industrial processes, and the growing toolbox of synthetic methods that favor them all encourage further exploration.
This shift encourages chemists to revisit long-standing design rules. With products like 2-Bromo-5-(Trifluoromethoxy)Aniline, speculative ideas about metabolic fine-tuning or late-stage diversification become more routine. This democratizes excellence—smaller teams or new entrants get the same access to versatile building blocks as the deep-pocketed corporations, provided they connect with quality suppliers and adopt best practices. The innovation wave moves outward, not just upward, as more labs access reliable intermediates for specialized needs.
Every time a new intermediate broadens the toolkit, the whole sector benefits. Specialty chemical development depends on access as much as inspiration. Where 2-Bromo-5-(Trifluoromethoxy)Aniline finds a place on the bench, it brings both new reactivity and a higher bar for performance and reliability. It encourages researchers to ask more of their building blocks and not settle for less than practical, flexible, and robust structures. In a setting marked by fast turnaround times and constant regulatory pressure, anything that saves time and increases success rates deserves genuine attention.
The lessons learned through daily practice—like the importance of reliable supply, batch-to-batch consistency, and knowing your intermediates inside out—shape how teams move new compounds from bench to real-world impact. The bridges between raw materials, finished products, and responsible handling begin with choices made in intermediate selection. In my own work, the most effective syntheses always started with intermediates that delivered not just on paper, but every time they hit the flask.
With every successful project built on a reliable starting point, the entire industry takes another step forward. Products like 2-Bromo-5-(Trifluoromethoxy)Aniline carry that progress in every gram, every batch, every innovative molecule that reaches its target. It stands as one example of how thoughtful design, smart sourcing, and rigorous attention to quality drive future breakthroughs for research and industry alike.
